Abraham Ceesay Insider Trades & Stock Holdings

Chief Executive Officer · Rapport Therapeutics, Inc. · Latest filing Oct 21, 2026

Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, Inc. has 6 Form 4 trades on file since Jun 29, 2026. Open-market activity: 0 purchases ($0) and 6 sales ($950.12K), net -$950.12K. Latest filing: disposed of 2.21K shares of $RAPP on Oct 21, 2026 at $29.16.

Trades on file
6
Open-market bought
$0
Open-market sold
$950.12K
Net open-market
-$950.12K
Shares held ($RAPP)
450.04K
Latest filing
Oct 21, 2026

Shares held by Abraham Ceesay

Shares owned after the most recent Form 4 for each company.

All insider trades by Abraham Ceesay

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$RAPP Sell (Open-market sale) 10b5-1 2.21K $29.16 $64.45K 450.04K -0.49% Chief Executive Officer SEC Read
$RAPP Sell (Open-market sale) 10b5-1 1.15K $30.66 $35.17K 452.25K -0.25% -8.2% Chief Executive Officer SEC —
$RAPP Sell (Open-market sale) 10b5-1 3.38K $32.03 $108.11K 453.39K -0.74% -6.9% Chief Executive Officer SEC —
$RAPP Sell (Open-market sale) 10b5-1 2.21K $39.17 $86.57K 456.77K -0.48% -1.6% Chief Executive Officer SEC —
$RAPP Sell (Open-market sale) 10b5-1 8.21K $40 $328.44K 539.82K -1.50% +2.7%+14.2% Chief Executive Officer SEC —
$RAPP Sell (Open-market sale) 10b5-1 8.22K $39.83 $327.40K 548.03K -1.48% -4.5%+1.4% Chief Executive Officer SEC —

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Abraham Ceesay traded

Frequently asked questions

Has Abraham Ceesay been buying or selling stock?

Abraham Ceesay has 0 open-market purchases and 6 open-market sales on file, net -$950.12K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Abraham Ceesay's latest insider trade?

disposed of 2.21K shares of $RAPP on Oct 21, 2026 at $29.16.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions